Skip to content
Private nicotine addiction treatment at Oasis Premium Recovery, Marbella Spain

100% Confidential

Addiction Treatment · Marbella, Spain

Nicotine Addiction Treatment

Private, one-to-one residential support for nicotine dependence and smoking cessation. Evidence-based, fully confidential — in Southern Spain.

For individuals who value complete discretion and a truly personalised approach

Fully confidential admissions
One-to-one only — no group settings
Nervous system and stress regulation
Evidence-based cessation support
WHAT WE TREAT

Nicotine Addiction: Scope of Care

Nicotine addiction is frequently underestimated as a clinical problem — partly because the substance is legal, partly because the consequences accumulate slowly, and partly because the dependence is so normalised it can be difficult to recognise as the serious medical condition it is.

We treat nicotine dependence with the same clinical rigour we apply to all addiction presentations — addressing physical dependence, psychological drivers, habitual triggers, and the stress regulation functions that smoking has served.

Nicotine dependence

Nicotine is one of the most addictive substances known — more so by some measures than alcohol or cocaine. Dependence develops rapidly, operates through powerful neurological reward pathways, and is reinforced by hundreds of daily behavioural rituals that become deeply integrated into how a person manages stress, transitions, and emotion. This is why willpower alone has a consistently poor success rate.

Physical withdrawal — irritability, poor concentration, anxiety, sleep disruption, and intense cravings — typically peaks in the first 72 hours and subsides over two to four weeks. Psychological dependence, which is where most relapses originate, takes considerably longer to address.

Forms of nicotine use we treat

Cigarettes, cigars, pipes, roll-your-own tobacco, snus and chewing tobacco, nicotine pouches, vaping and e-cigarettes, heated tobacco products, and dual-use patterns where multiple forms are combined. Vaping in particular presents a distinct clinical profile — often with higher nicotine concentrations than cigarettes and use patterns that are more continuous and less socially regulated.

Co-occurring conditions

Nicotine dependence frequently co-occurs with anxiety, depression, stress-related burnout, ADHD, alcohol use, and other substance dependencies. In many cases, smoking has functioned as self-medication — a readily available, socially normalised mechanism for managing arousal, focus, and mood regulation. Cessation support that ignores these underlying functions rarely holds.

Recognising the pattern

Signs of Nicotine Dependence

Nicotine dependence operates on two levels simultaneously — physical withdrawal that drives the compulsion to use, and psychological habituation that embeds smoking into hundreds of daily cues and routines. Both require clinical attention.


  • Repeated failed quit attempts despite genuine motivation to stop
  • Smoking within minutes of waking — a strong indicator of physical dependence severity
  • Anxiety, irritability, or inability to concentrate when unable to smoke
  • Deeply ingrained situational rituals — after meals, with coffee, during stress, after work
  • Continued smoking despite clear health consequences or medical advice to stop
  • Failed transitions from cigarettes to vaping, or continuous vaping with no reduction in intake
  • Organising daily life around smoking — breaks, locations, travel, and social contexts
  • Nicotine use tightly linked to alcohol, caffeine, stress, or mood — making isolated cessation attempts difficult

Clinical assessment

Mapping the Dependence

A thorough assessment precedes every programme. We build a complete picture across six areas — because cessation that addresses only the physical component while ignoring triggers, stress regulation, and prior quit history has a predictably poor success rate.


Use profile

Products used, daily quantity, time to first cigarette, vaping frequency, quit history, and longest abstinence periods. The pattern of use informs the physical dependence severity and the appropriate level of pharmacological support.

Triggers and rituals

Situational cues — stress, meals, alcohol, social contexts, transitions between tasks — and the habitual rituals that are woven into daily structure. Trigger mapping is the basis of the behavioural component of cessation planning.

Stress and mood regulation

The emotional function that nicotine has served — anxiety management, focus, mood stabilisation, boredom relief. Understanding what nicotine has been doing means designing effective replacements, not just removing the substance.

Sleep and physiology

Sleep quality, morning readiness, caffeine use, movement, and nutrition. Nicotine withdrawal significantly disrupts sleep in the first two weeks, and sleep quality is a strong predictor of cessation success.

Co-occurring substance use

Alcohol, caffeine, and other substance use that is linked to smoking patterns. Alcohol in particular is strongly associated with relapse in nicotine cessation and requires direct clinical attention where present.

Quit history and barriers

Previous cessation attempts, methods used, duration achieved, and the specific circumstances of each relapse. Quit history is one of the most clinically useful predictors of what a new attempt requires to succeed.

CLINICAL APPROACH

Our Approach to Nicotine Cessation

Effective nicotine cessation combines pharmacological support for physical withdrawal with psychological therapy for habitual triggers, stress regulation work for the emotional function smoking has served, and environment design to reduce cue-driven relapse.

Nicotine replacement therapy (NRT), varenicline, and bupropion are all evidence-based options that reduce withdrawal severity and improve cessation rates significantly when used alongside behavioural support. A physician assesses suitability and manages any pharmacological component — we do not prescribe or alter doses. The clinical evidence is clear: pharmacological support combined with behavioural intervention produces substantially better outcomes than either alone.

CBT identifies automatic thoughts about smoking — stress relief, reward, social belonging, concentration — and builds alternative cognitive and behavioural responses. For long-term smokers, many of these automatic associations are deeply ingrained and require sustained clinical attention rather than a single intervention session.

Resolves ambivalence about quitting, clarifies the personal values and health goals that motivate change, and converts intention into a specific, realistic cessation plan. Many long-term smokers have mixed feelings about stopping — MET works with that ambivalence constructively rather than assuming a readiness that may not yet be fully present.

TRE, functional breathwork, progressive movement, and sleep optimisation to build a physiological stress regulation toolkit that replaces the role nicotine has played. This is not optional supplementary content — for clients whose smoking is tightly linked to anxiety or stress, somatic regulation is the core of sustainable cessation.

A detailed map of situational and emotional triggers — with specific alternative responses designed for each — and practical environment changes that reduce cue exposure in the early weeks. Removing ashtrays is the obvious starting point; the clinical work goes considerably deeper.

Alcohol is the single strongest situational trigger for smoking relapse. Where alcohol use is part of the pattern, it is addressed directly within the programme rather than treated as a separate issue. This does not necessarily mean abstinence from alcohol — it means building specific rules and skills for managing high-risk social and drinking contexts.

Tried Before and Not Made It Stick?

Most people who successfully quit smoking have made multiple previous attempts. Each attempt that doesn't work is clinically useful information about what the next one needs. A confidential conversation with our team is a good place to start building a plan that addresses what the previous ones missed.

Every programme is one-to-one. The clinical dose is calibrated to dependence severity, co-occurring conditions, and the complexity of the quit history. A typical week includes:

Weekly clinical dose:

  • 7–10 hours of individual psychotherapy per week — focused on habitual triggers, motivational work, cognitive restructuring, and the stress regulation functions that nicotine has served.

  • 3–5 hours of skills and planning work per week — trigger mapping, craving management scripts, high-risk situation protocols, and relapse prevention for social and alcohol-linked contexts.

  • 2–4 hours of somatic regulation per week — breathwork, TRE, and movement to build the physiological stress regulation capacity that replaces nicotine's role in the nervous system.

  • Protected integration time daily — nature, rest, and structured offline time so new patterns consolidate. Physical withdrawal typically peaks in the first 72 hours and improves steadily across the first two weeks with consistent support.

SAMPLE PATHWAYS

Two Sample Treatment Pathways

Every programme is tailored to the individual. These two pathways illustrate how the clinical framework is applied across the most common presentations we treat.

Week 1: Medical assessment and NRT initiation if indicated, Fagerström dependence scoring, CBT trigger mapping, MET values and health goals work, breathwork and TRE, environment design, and first craving management plan.

Week 2: Deeper CBT work on automatic smoking associations, somatic stress regulation practice, alcohol and social context protocols, sleep optimisation, and aftercare calendar.

Weeks 3 to 4: Stress testing with graded re-exposure to high-risk contexts — work pressure, social drinking, morning routine — and step down to structured follow-ups.

Week 1: Vaping profile assessment and step-down plan, CBT psychoeducation on nicotine's role in anxiety amplification, MET to resolve ambivalence, TRE, sleep and caffeine timing, and first 24-hour abstinence milestone.

Week 2: Anxiety management without nicotine, DBT distress tolerance for craving peaks, trigger mapping for device-linked habits, and aftercare plan.

Weeks 3 to 4: Graded reduction to zero, high-risk social situation protocols, and step down to structured follow-ups.

RELAPSE PREVENTION & AFTERCARE

Sustaining Cessation After Treatment

The residential programme gives you the controlled conditions to get through withdrawal and build the foundations of a smoke-free routine. Aftercare gives you the clinical support to hold it when those conditions are gone and real life resumes.

The first 90 days after discharge are the highest-risk period. We design aftercare around that window specifically.

What you leave with

A written cessation plan, a trigger map with specific responses for each high-risk situation, a 90-day calendar for the highest-risk periods, and scheduled follow-up sessions. If pharmacological support is ongoing, physician coordination continues after discharge.

Managing slips and relapse

A slip — a single cigarette or vaping episode — is not a failed quit. It is clinically important information. We build a specific slip management protocol into every programme: what to do in the moment, how to interrupt escalation, and how to use the experience to strengthen the plan rather than abandon it.

Ongoing support

Lifetime Aftercare with scheduled follow-up sessions. The first three months after cessation are the highest-risk period for relapse — structured aftercare during this window makes a clinically significant difference to long-term outcomes.

How to Start

The admissions process is straightforward and fully confidential. Most clients move from first enquiry to confirmed programme within a few days.

  • 1
    Step 1

    Send a confidential enquiry

    Share a brief outline of your situation and goals — including any previous quit attempts and what you know about what didn't work.

  • 2
    Step 2

    Pre-admission assessment

    We review dependence severity, quit history, co-occurring conditions, and practical needs via secure video. Pharmacological support options are discussed at this stage.

  • 3
    Step 3

    Receive a tailored cessation plan

    We propose programme length, focus areas, and NRT or pharmacological support where indicated. You review and confirm before anything is booked.

  • 4
    Step 4

    Plan your travel

    We arrange your arrival and private ground transfer. The residence is smoke-free — the first step in environment design begins before clinical work starts.

  • 5
    Step 5

    First 72 hours

    The most intense withdrawal phase. Clinical support, pharmacological management if in place, breathwork, sleep optimisation, and structured distraction during peak craving windows.

  • 6
    Step 6

    Step down and aftercare

    Continue with structured aftercare through the highest-risk 90-day window. Your trigger map, cessation plan, and follow-up sessions are confirmed before you leave.

Your questions answered

Frequently Asked Questions

If you’re considering a private luxury rehab centre for yourself or someone you love, we’re here to help you take the next step with clarity and discretion.

Still have questions? Our admissions team is available 24 hours a day for confidential conversations.

Speak With Us in Confidence